SERION ELISA agile

SARS-CoV-2

SERION ELISA agile SARS-CoV-2 IgA and IgG tests are qualitative and quantitative immunoassays for the detection of human antibodies in serum or plasma directed against SARS-CoV-2 and are recommended to support in the diagnosis of COVID-19 and as a complement to direct pathogen detection. In addition SERION ELISA agile SARS-CoV-2 IgG can be used for epidemiological studies.

Highlights

  • The utilization of the whole spike protein ensures an early and sensitive detection of SARS-CoV-2 IgG
  • Sensitive IgA antibody detection with high specificity ideal for determination of acute infections as complement to direct pathogen detection
  • Specific IgG test for epidemiological studies, determination of the immune status and to analyze pandemic progression
  • Quantitative evaluation of IgA and IgG antibody titers
  • Free from cross-reactions against other pathogens, also from the corona virus family

Products

SARS-CoV-2 IgA
SERION ELISA agile
ESR400A
SARS-CoV-2 IgG
SERION ELISA agile
ESR400G
SARS-CoV-2 IgM
SERION ELISA agile 
ESR400M